TīmeklisCD38 density is not sufficient to enable CDC • ISB 1442 induces comparable killing of CD38. high. expressing tumor cells to daratumumab • In NCI-H929 tumor cells, ISB … Tīmeklis2024. gada 13. nov. · Of note, in those cell lines that were responsive to daratumumab in CDC assays (>50% tumor cell lysis), CDC activity of HexaBody-CD38 was superior to daratumumab, with IC50 values for HexaBody-CD38 2.4- to 13-fold lower than for daratumumab. Moreover, HexaBody-CD38 unlocked CDC activity in 17 out of 28 …
Raji - CCL-86 ATCC
Tīmeklis2024. gada 5. nov. · HexaBody ®-CD38 (GEN3014) is a next-generation CD38-specific IgG1 molecule with a hexamerization-enhancing mutation that leads to highly efficient induction of complement-dependent cytotoxicity (CDC) upon binding to CD38 positive tumor cells.HexaBody-CD38 is designed to induce strong anti-tumor activity in … TīmeklisRaji. CCL-86 ™. The Raji line of lymphoblast-like cells was established by R.J.V. Pulvertaft in 1963 from a Burkitt's lymphoma of the left maxilla of an 11-year-old … goliath rachel
Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant
Tīmeklis2024. gada 28. apr. · In addition, introduction of the E430G mutation unlocked CDC activity of the CD37 mAbs in Raji cells (EC 50 ranging from 0.29 to 0.77 µg/ml), … TīmeklisNational Center for Biotechnology Information Tīmeklis2024. gada 22. apr. · CD38-directed antibodies have several mechanisms of action. Fc-dependent immune effector mechanisms include complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP) and apoptosis. In addition, direct effects and … health care premium increases 2016